Search
for
Sort by
Research 271–300 of 1000+
- Reproductive seasonality and maturation throughout the complete life-cycle in the mouflon ram (Ovis musimon)
- Polycystic Ovarian Syndrome
- Hormonal contraceptives: pharmacology tailored to women's health
- Health and fertility in World Health Organization group 2 anovulatory women
- Finasteride
- Circadian clocks: from stem cells to tissue homeostasis and regeneration
- Neurosteroids, neuroactive steroids, and symptoms of affective disorders
- Hair Loss in Women
- Current evaluation of amenorrhea
- Diagnosis of hyperandrogenism: Biochemical criteria
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- Androgens and Female Sexual Function and Dysfunction—Findings From the Fourth International Consultation of Sexual Medicine
- MENSTRUAL DISORDERS IN ADOLESCENTS
- Repurposing of approved cardiovascular drugs
- PCOS in adolescents
- Electrospun Nanofibers for Improved Angiogenesis: Promises for Tissue Engineering Applications
- Semen Parameters Among Transgender Women With a History of Hormonal Treatment
- Mood and Sexual Function in Polycystic Ovary Syndrome
- The Modulatable Stem Cell Niche: Tissue Interactions during Hair and Feather Follicle Regeneration
- Menstrual Irregularity in Women with Acromegaly
- How should postmenopausal androgen excess be evaluated?
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Clinical, metabolic, and endocrine parameters in response to metformin and lifestyle intervention in women with polycystic ovary syndrome: A randomized, double-blind, and placebo control trial
- Polycystic ovary syndrome and insulin-resistant hyperinsulinemia
- Sex Hormone-Binding Globulin (SHBG) as an Early Biomarker and Therapeutic Target in Polycystic Ovary Syndrome
- A practical guide for the study of human and murine sebaceous glands <i>in situ</i>
- Nonclassic adrenal hyperplasia
- Differential Expression of miR-93 and miR-21 in Granulosa Cells and Follicular Fluid of Polycystic Ovary Syndrome Associating with Different Phenotypes
- Steroidal 5α-reductase and 17α-hydroxylase/17,20-lyase (CYP17) inhibitors useful in the treatment of prostatic diseases
- The therapeutic use of androgens in women